Effects of Dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy

Effects of dexmedetomidine or esmolol on inflammatory responses in patients undergoing laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000399

Enrollment

Registered

2012-04-09

Start date

2011-03-03

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : infused with a 1.0mg/kg loading dose of dexmedetomidine for 10 minutes followed by an infusion of 0.5mcg/kg/min

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic cholecystitis, gall bladder polyp, biliary colic

Exclusion criteria

Exclusion criteria: acute cholecystitis, gall bladder empyema, fever, leukocytosis, diabetes mellitus, hypertension, coronary artery disease, arrhythmia

Design outcomes

Primary

Measure	Time frame
cytokines concentration	—

Secondary

Measure	Time frame
C-reactive peptide;white blood cell count	—

Countries

Korea, Republic of

Contacts

Public Contactsunghee Kang

The Catholic University of Korea, Incheon St. Mary's Hospital

Outcome results